BioCentury
ARTICLE | Company News

SuperGen, Barr Laboratories Inc. deal

July 29, 1996 7:00 AM UTC

SUPG acquired non-exclusive rights from Barr to market three generic anticancer products. The products are oral formulations of methotrexate, megestrol acetate and calcium leucovorin. Barr will manufa...